✦ LIBER ✦

Epirubicin/paclitaxel/carboplatin (TEC) vs paclitaxel/carboplatin in first line treatment of ovarian carcinoma figo stage II b-IV. Preliminary results. A GINECO randomized trial

✍ Scribed by Weber, B.; Kuhn, W.; Goupil, A.; Blohmer, J.; Guichard, F.; Quaas, J.; Lucas, V.; Schröder, W.; Plaza, J.; du Bois, A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epirubicin/paclitaxel/carboplatin (TEC)

✍ E. PUJADE-LAURAINE; A. du BOIS; A. GOUPIL; J. ROCHON; V. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB

36 Paclitaxel/Carboplatin(TC) vs Paclita

✍ E. Pujade-Lauraine; J. Pfisterer; A. Lortholary; R. Kimmig; B. Weber; A. du Bois 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Randomized phase II trial of carboplatin

✍ Werner Meier; Andreas du Bois; Jörn Rau; Martina Gropp-Meier; Klaus Baumann; Jen 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 336 KB

First-line treatment of ovarian/tubal/pe

✍ G.B. KRISTENSEN; I. VERGOTE; G. STUART; J.M. Del CAMPO; J. KÆRN; M. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 27 KB

Randomized phase 3 trial of interferon g

✍ David S. Alberts; Christian Marth; Ronald D. Alvarez; Gary Johnson; Mariusz Bidz 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 233 KB